Safety and Efficacy of HarmonyTM Transcatheter Pulmonary Valve Implantation ― Clinical and Hemodynamic Assessment in a Single-Center Japanese Cohort ―
Year: 2026
Type: article
Abstract: BACKGROUND: transcatheter pulmonary valve implantation (TPVI) was developed to treat pulmonary regurgitation (PR) in patients with an enlarged native right ventricular outflow tract. Favorable outcomes have been reported in cohorts from the USA, but data from other regions are limited. METHODS AND RESULTS: (P<0.05). During a median follow-up of 17 months, all patients remained free from reintervention. CONCLUSIONS: TPVI achieved high procedural success and rapid right ventricular reverse remodeling, indicating it is a safe and effective treatment option.
Source: Circulation Journal
Institution: Tokyo Women's Medical University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7128311474
